Advancing the Cardiovascular Care of the Oncology Patient – On Demand

Advancing the Cardiovascular Care of the Oncology Patient

Advancing the Cardiovascular Care of the Oncology Patient – On Demand provides clinicians and researchers with the tools needed to improve patient care in your everyday practice. Register today for this educational experience designed for you to stay on the leading edge of this rapidly evolving field! Experience ALL educational sessions On Demand, including case discussions on evidence-based treatment strategies with practical tips to comprehensively care for your cancer patients and survivors.

Statement of Need
Cancer remains the second leading cause of death in the United States, exceeded only by heart disease, with an estimated 1.8 million new cases in 2020. Cancer treatment can have a diverse array of long-term and late effects, including cardiovascular events such as heart failure, valvular damage, coronary artery disease, and cardiac dysfunction. In this contemporary treatment era, cardiologists, oncologists, and the entire interprofessional team need to understand the different types of cancer therapies (e.g., cytotoxic chemotherapy, radiation therapy, transplantation, targeted and immune therapies) to help mitigate the associated cardiovascular complications.

The goal of this course is to improve awareness, identification, monitoring, and management of cardiovascular disease and conditions, and minimize cardiotoxicity from anticancer therapies to improve overall survival and quality of life of the oncology patient.

Learning Objectives
Upon completion of this educational activity, participants will be able to:

  • Discuss the different types, oncologic indications, and mechanisms of action of conventional and modern cancer therapies, their associated cardiotoxicities, and the risks of developing cardiovascular risk factors and cardiovascular disease.
  • Recognize guideline recommendations regarding risk stratification, monitoring, and management strategies to mitigate cardiovascular risk in the oncology patient.
  • Apply evidence-based strategies for short- and long-term surveillance and management of cardiotoxicities in patients with active cancer and survivors who have been treated with high cardiovascular risk systemic therapies including, but not limited to, anthracyclines, androgen deprivation therapies, hormone therapies, HER2+ targeted therapies, tyrosine kinase inhibitors, stem cell transplantation, and radiation therapy.
  • Define the evidence behind the role of preventive and therapeutic pharmacologic and non-pharmacologic interventions in the management of cardiotoxicity.
    Recognize the overlap between cancer and cardiovascular disease, independent of the cardiotoxicity of cancer therapies (e.g., clonal hematopoiesis, epidemiologic risk factors, basic mechanisms).
  • Discuss the pathophysiologic basis of amyloidosis, as well as diagnostic and treatment strategies.
  • Design an interprofessional cardio-oncology care team and a framework to improve the overall cardiovascular care of cancer patients and survivors.
  • Describe the impact of health disparities, genomic ancestry, and social determinants of health in cardiovascular disease and cancer.

Target Audience
This educational activity is intended to address the educational needs of cardiologists, oncologists, internists, pharmacists, nurses, and all members of the interprofessional care team who provide healthcare to the growing population of cancer patients and survivors with cardiovascular concerns.

Course Directors

Ana Barac, MD, PhD, FACC
Medstar Heart and Vascular Institute

Bonnie Ky, MD, MSCE, FACC
University of Pennsylvania School of Medicine

Planning Committee

Alicia K. Morgans, MD, MPH
Dana-Farber Cancer Institute

Christine Cambareri, PharmD, BCPS, BCOP
Hospital of the University of Pennsylvania

Kerry Skurka, RN
Franciscan Health

Mary Branch, MD
Wake Forest Baptist Health

Ronald Witteles, MD, FACC
Stanford University

Plenary Speakers

Dipti Itchhaporia, MD, FACC
American College of Cardiology

Lidia Schapira, MD
Massachusetts General Hospital


Daniel Addison, MD
Ohio State University

Greg Armstrong, MD, MSCE
St. Jude Children's Research Hospital

Sherry-Ann Brown, MD, PhD, FACC
Medical College of Wisconsin

Atul R. Chugh, MBBS, FACC
Franciscan Health

Rudolf A. de Boer, MD
University Medical Center Groningen

Benjamin Ebert, MD, PhD
Dana-Farber Cancer Institute

Michael Fradley, MD
University of Pennsylvania

Betty Hamilton, MD
Cleveland Clinic

Carrie Lenneman, MD, FACC
University of Alabama at Birmingham

Darryl Leong, MBBS
McMaster University

Michaela Liedtke, MD
University of Stanford

Ariane Vieira Scarlatelli Macedo, MD
Santa Casa de Misericórdia de São Paulo

Raymond H. Mak, MD
Dana-Farber Cancer Institute

Josh Mitchell, MD, FACC
Washington University in St. Louis

Vivek Narayan, MD, MSCE
University of Pennsylvania, Abramson Cancer Center

Tomas G. Neilan, MD, MPH, FACC
Massachusetts General Hospital

Ann Partridge, MD, MPH
Dana-Farber Cancer Institute

Vijay Rao, MD, PhD, FACC
St Francis Medical Group

David Reeves, PharmD, BCOP
Butler University

Kerry Reynolds, MD
Massachusetts General Hospital

Diego Sadler, MD, FACC
Cleveland Clinic Florida

Jessica Scott, PhD
Memorial Sloan Kettering Cancer Center

Kerry Skurka, RN
Franciscan Health

Lova L. Sun, MD, MSCE
University of Pennsylvania

Deborah W. Sundlof, DO, FACC
Lehigh Valley Hospital

Dinesh Thavendiranathan, MD, MSc, FASE
Toronto General Hospital

Raymond R. Townsend, MD
University of Pennsylvania

Sujethra Vasu, MD
Wake Forest Baptist Health

Faculty are subject to change without notice.

Disclosure/Conflict of Interest Statement

As a provider jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), the American College of Cardiology Foundation (ACCF) must ensure balance, independence, objectivity and scientific rigor in all of their directly provided or jointly provided/co-provided educational activities. Planners, presenters, and other contributors, in a position to control the content are required to disclose to the audience all relevant financial relationships he/she and/or his/her spouse or domestic partner may have, occurring within the past 24 months, with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. When an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, the contributor should disclose that the product is not labeled for the use under discussion or that the product is still investigational.

ACCF is committed to providing its learners with high-quality activities and materials that promote improvements and quality in health care and not a specific proprietary business or commercial interest. The intent of this disclosure is not to prevent participation in educational activities by persons with a financial or other relationship, but rather to provide learners with information on which they can make their own determination whether financial interests or relationships may influence the education activity.

ACCF assesses conflicts of interest (COI) with its faculty, planners, managers, staff and other individuals who are in a position to control the content of certified activities. All relevant potential conflicts of interest that are identified are thoroughly vetted by course directors, ACCF education staff, and members of the Accreditation Compliance Workgroup (ACWG) through a process that includes appropriate peer review for fair balance, scientific objectivity and validity, and patient care and safety recommendations.

ACCF has taken the necessary steps to ensure that all relevant financial relationships have been mitigated.

Please note ACCF staff and the ACWG members involved with this activity have nothing to disclose.

Joint Accreditation Statement

In support of improving patient care, the American College of Cardiology Foundation (ACCF) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation Statements

The ACCF designates this other activity (live virtual and on demand) for a maximum of 26 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification (MOC) Information
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 26 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.

Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

The ACCF designates this educational activity for a maximum of 26 continuing nursing education contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.

Physician Assistants
Other Activity (live virtual and on demand)
The American College of Cardiology Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 26 AAPA Category 1 CME credits.

Approval is valid until May 16, 2022. PAs should only claim credit commensurate with the extent of their participation.

ACCF designates this continuing education activity for 20.75 contact hours (2.075 CEUs) of the Accreditation Council for Pharmacy Education.

This activity was planned by and for the healthcare team, and learners will receive 15 Interprofessional Continuing Education (IPCE) credits for learning and change.

While offering credits noted above, the course is not intended to provide extensive training or certification in this field.

  • Online: Click the Register button at the top of the page
  • Phone: 800-253-4636, ext. 5603 or 202-375-6000, ext. 5603

Registration for Advancing the Cardiovascular Care of the Oncology Patient – On Demand includes access to ALL educational sessions On Demand and additional content through May 16, 2022. Registration is open until May 2, 2022.

Registration Fees
Rate Type Example Designations Early Until 12/21/2021 Regular After 12/22/2021
Member Physician (includes International Associate) MD, DO $249 $299
Emeritus Member   $149 $199
Non-member Physician MD, DO $349 $399
AACC/CCA Member (includes CVT Member) PA, RN, NP, CNS, PharmD $149 $199
CCA Non-member PA, RN, NP, CNS, PharmD $249 $299
FIT, Resident, Student Member FIT, Resident, and Student $149 $199
FIT, Resident, Student Non-member FIT, Resident, and Student $249 $299
Industry Professional   $349 $399

Cancellation, substitution, or transfer to another course is allowed if written notification is received four weeks before a scheduled course. A full refund minus a $50 processing fee will be given for written notifications received fewer than four weeks before the first day of the course. No refund will be given for no-shows.

ACC reserves the right to cancel the course in the unlikely event of insufficient enrollment or other unforeseen circumstances. In the unlikely event that the course is canceled, the College will refund the registration fee in full.

Clinical Topics: Cardio-Oncology